ProKidney

(NASDAQ) PROK

Current Price$1.86

Market Cap$264.10M

Since IPO (2021)-82%

5 YearN/A

1 Year+166%

1 Month+1%

ProKidney Financials at a Glance

Market Cap

$264.10M

Revenue (TTM)

$893.00K

Net Income (TTM)

$68.99M

EPS (TTM)

$-0.52

P/E Ratio

-3.61

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.86

Volume

21,562

Open

$1.89

Price

$1.86

Volume

21,562

Open

$1.89

Previous Close

$1.86

Daily Range

$1.85 - $1.90

52-Week Range

$0.54 - $7.13

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.86

Volume

21,562

Open

$1.89

Previous Close

$1.86

Daily Range

$1.85 - $1.90

52-Week Range

$0.54 - $7.13

PROK News

ProKidney Reports 78 Percent Gain in Q2

Motley Fool Markets TeamAug 12, 2025

Meet the Biotech Stock That Rocketed 775% Higher

Cory RenauerJul 22, 2025

This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy?

David Jagielski, CPAJul 17, 2025

Why Shares of ProKidney Were Dropping Thursday

James HalleyOct 12, 2023

PROK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProKidney

Industry

Biotechnology

Sector

Health Care

Employees

231

CEO

Bruce Culleton, MD, MBA

Website

www.prokidney.com

Headquarters

Winston-Salem, NC 27103, US

PROK Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-185%

Net Income Margin

-77%

Return on Equity

Return on Capital

-54%

Return on Assets

-21%

Earnings Yield

-27.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$264.10M

Shares Outstanding

141.99M

Volume

21.56K

Avg. Volume

799.65K

Financials (TTM)

Gross Profit

$4.83M

Operating Income

$165.01M

EBITDA

$158.97M

Operating Cash Flow

$120.12M

Capital Expenditure

$15.20M

Free Cash Flow

$135.31M

Cash & ST Invst.

$270.02M

Total Debt

$2.96M

ProKidney Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$225.00K

+196.1%

Gross Profit

$1.22M

-1710.5%

Gross Margin

-5.44%

N/A

Market Cap

$264.10M

N/A

Market Cap/Employee

$1.29M

N/A

Employees

204

N/A

Net Income

$19.23M

+9.6%

EBITDA

$43.92M

+2.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$267.05M

-24.8%

Accounts Receivable

$1.13M

-53.9%

Inventory

$0.00

N/A

Long Term Debt

$2.96M

+20.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-20.56%

N/A

Return on Invested Capital

-54.13%

N/A

Free Cash Flow

$38.27M

+23.0%

Operating Cash Flow

$32.51M

-34.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RZLTRezolute, Inc.

RZLTRezolute, Inc.$3.21+4.05%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$3.21+3.05%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$9.42+1.07%

SVRASavara Inc.

SVRASavara Inc.$5.23+1.36%

SEPNSepterna, Inc.

SEPNSepterna, Inc.$23.87-0.46%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$13.66+1.86%

BCAXBicara Therapeutics Inc. Common Stock

BCAXBicara Therapeutics Inc. Common Stock$22.58-2.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

Questions About PROK

What is the current price of ProKidney?

ProKidney is trading at $1.87 per share.

What is the 52-week range for ProKidney?

Over the past 52 weeks, ProKidney has traded between $0.54 and $7.13.

How much debt does ProKidney have?

As of the most recent reporting period, ProKidney reported total debt of $4.04M.

How much cash does ProKidney have on hand?

ProKidney reported $108.54M in cash and cash equivalents in its most recent financial results.

What is ProKidney’s dividend yield?

ProKidney does not currently have a dividend yield.

ProKidney

ProKidney Financials at a Glance

PROK News

ProKidney Reports 78 Percent Gain in Q2

Meet the Biotech Stock That Rocketed 775% Higher

This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy?

Why Shares of ProKidney Were Dropping Thursday

PROK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ProKidney

PROK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ProKidney Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PROK

What is the current price of ProKidney?

What is the 52-week range for ProKidney?

How much debt does ProKidney have?

How much cash does ProKidney have on hand?

What is ProKidney’s dividend yield?

Premium Investing Services